Publications

5891 Results

Long-term survival analysis ofthe North American Intergroup study C9011 comparing fludarabine (f) and chlorambucil (c) in previously untreated patients with chronic lymphocytic leukemia (CLL)

Authors
K Rai;BL Peterson;FR Appelbaum;M Tallman;A Belch;VA Morrison;RA Larson
Journal / Conference
Blood 114:abstr #536 (ASH 2009 Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

The influence of older age on physician and patient decision-making regarding enrollment to breast cancer clinical trials

Authors
S Javid;J Unger;J Gralow;C Moinpour;A Wozniak;JW Goodwin;P Lara;P Williams;L Hutchins;C Gotay;K Albain
Journal / Conference
San Antonio Breast Cancer Symposium, poster, abst. #3077
Year
2009
Research Committee(s)
Cancer Survivorship
Study Number(s)
S0316

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine/cytarabine for relapsed/refractory acute lymphocytic leukemia

Authors
A Advani;H Gundacker;L Sala-Torra;J Radich;R Lai;J Lancet;S Coutre;RK Stuart;MP Mims;P Stiff;F Appelbaum
Journal / Conference
Blood 114:abst. #3094, 2009 (poster presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
S0530

Lack of low-risk pathologic findings in SWOG 8794

Authors
G Swanson;B Goldman;C Tangen;IM Thompson;J Chin;E Messing;E Canby-Higano;J Forman;E Crawford
Journal / Conference
International Journal of Radiation Oncology, Biology & Physics 75(S):abst #20, S10, 2009 (oral pres., ASTRO)
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Results of chemotherapy alone, with sequential or concurrent addition of 52 weeks of trastuzumab in the NCCTG N9831 HER2-positive adjuvant breast cancer trial

Authors
E Perez;VJ Suman;NE Davidson;J Gralow;P Kaufman;JN Ingle;SR Dakhil;J Zujewski;TM Pisansky;R Jenkins
Journal / Conference
San Antonio Breast Cancer Symposium abst. #80 (annual meeting, general session)
Year
2009
Research Committee(s)
Breast
Study Number(s)
N9831

Biased hormonal therapy duration analysis makes results uninterpretable [PMID19786655]

Authors
CM Tangen;BH Goldman;GP Swanson;IM Thompson
Journal / Conference
Journal of Clinical Oncology 27(33):e203
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Chemoprevention of prostate cancer. PMID: 19524966

Authors
IM Thompson;CM Tangen;P Goodman;MS Lucia;E Klein
Journal / Conference
Journal of Urology 182(2):499-507
Year
2009
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment [PMID19858397]

Authors
PA Philip;M Mooney;D Jaffe;G Eckhardt;M Moore;N Meropol;L Emens;E O'Reilly;M Korc;L Ellis;J Benedetti;M Rothenberg;C Willett;M Tempero;A Lowy;J Abbruzzese;D Simeone;S Hingorani;J Berlin;J Tepper
Journal / Conference
Journal of Clinical Oncology 27(33):5660-5669
Year
2009
Research Committee(s)
Gastrointestinal
PMC
n/a (review)

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803 [PMC2787689; PMID19934290]

Authors
S Ogino;JA Meyerhardt;D Niedzwiecki;D Hollis;L Saltz;RJ Mayer;P Schaefer;R Whittom;A Hantel;AB Benson;RM Goldberg;M Bertagnolli;C Fuchs
Journal / Conference
Clinical Cancer Research 15(23):7322-7329
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Cooperative group research endeavors in small-cell lung cancer: current and future directions [PMID19808190]

Authors
R Sangha;P Lara;AA Adjei;P Baas;H Choy;L Gaspar;G Goss;N Saijo;JH Schiller;EE Vokes;D Gandara
Journal / Conference
Clinical Lung Cancer 10(5):322-330
Year
2009
Research Committee(s)
Lung
PMC
n/a (review)
Study Number(s)
S0124